Neupogen
Active Ingredient(s): Filgrastim, G-CSFFDA Approved: * February 20, 1991
Pharm Company: * AMGEN
Category: Cancer
Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count.[6] Low neutrophil counts may occur with HIV/AIDS, following chemotherapy or radiation poisoning, or be of an unknown cause.[6] It may also be used to increase white blood cells for gathering during leukapheresis.[6] It is given either by injection into a vein or under the skin.[6] Common side effects include fever, cou... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.2 Discussions
Dosage List
Neupogen 300 ug/ml Intravenous Injection, Solution
NDC: 54868-2522
Labeler:
Physicians Total Care, Inc.
Neupogen 480 ug/.8ml Intravenous Injection, Solution
NDC: 54868-3050
Labeler:
Physicians Total Care, Inc.
Neupogen 300 ug/.5ml Intravenous Injection, Solution
NDC: 54868-5020
Labeler:
Physicians Total Care, Inc.
Neupogen 480 ug/.8ml Intravenous; Subcutaneous Injection, Solution
NDC: 55513-209
Labeler:
Amgen Inc
Neupogen 480 ug/1.6ml Intravenous; Subcutaneous Injection, Solution
NDC: 55513-546
Labeler:
Amgen Inc
Neupogen 300 ug/.5ml Intravenous; Subcutaneous Injection, Solution
NDC: 55513-924
Labeler:
Amgen Inc
Popular Topics
side effects,neupogen
stimulates white blood cells...
